The Best Nuclear Energy Stocks to Buy and Hold for Decades

The article argues that nuclear power could become a key enabler of AI-driven electricity demand, highlighting Oklo's developing Aurora reactor and NuScale's NRC-approved 50 MW and 77 MW SMR designs. Oklo remains pre-revenue with a roughly $33 million Q1 net loss and $1.6 billion in cash, while NuScale stands out for regulatory approval but still lacks significant revenue or a first firm sale. The piece is constructive on the long-term nuclear theme, but near-term implications for the stocks are volatile and limited by execution and regulatory risk.

Analysis

The market is starting to price nuclear as a data-center capacity solution rather than a power-generation story, and that changes the winner set. The near-term beneficiaries are not the reactor developers themselves but the adjacent enabling ecosystem: uranium supply, fuel handling, EPC/engineering, and industrial electrical infrastructure that can monetize orders before a single commercial reactor is grid-connected. That matters because the first leg of the trade is likely capex, not revenue — meaning stocks tied to construction, grid interconnection, and specialized components can re-rate earlier than pure-play SMR names.

Second-order, the biggest competitive gap is execution credibility versus application fit. The company with the cleaner regulatory path should win utility partnerships, but utilities are slow buyers; the company with the more flexible deployment thesis may capture data-center demand faster even if its licensing timeline is messier. That creates a split market where investors are paying for optionality on one side and de-risking on the other, which can keep both names volatile while the broader supply chain quietly benefits from multiple shots on goal.

The contrarian risk is that AI-driven power demand is real, but the monetization timeline is longer than the market is discounting. If permitting, financing, or site selection slips by even 12-18 months, the stocks can de-rate sharply because today’s valuations already embed a steep probability of eventual success. The more interesting reversal trigger is policy: a shift in federal support or a standardized licensing framework would compress the regulatory discount much faster than any single project milestone.

Net-net, this is a theme where the best risk/reward may sit one layer removed from the headline names. The pure plays can work, but the cleaner expression is a basket approach that captures the infrastructure buildout while avoiding binary licensing risk.

Key Decisions for Investors

• Long a basket of nuclear-enabling infrastructure names vs. a short basket of the most dilutive pure-play reactor developers for the next 6-12 months; the thesis is that revenue recognition arrives first in grid, electrical, and engineering spend, while reactor cash flows stay delayed.
• For higher beta exposure, buy OKLO call spreads 6-12 months out instead of common stock; this preserves upside if a licensing catalyst lands while limiting downside if regulatory timelines slip another 12-18 months.
• Own SMR on pullbacks as the lower-regulatory-risk SMR expression, but size smaller than a typical growth position; upside is better tied to utility procurement, yet the stock remains vulnerable to long-cycle deal timing.
• Consider a pair trade long uranium/fuel-cycle beneficiaries and short an overowned nuclear concept name if the tape starts rewarding execution over narrative; that trade should work over 3-9 months if project delays accumulate.
• Add a watchlist trigger for federal policy headlines or standardized SMR permitting; if that catalyst emerges, expect the whole group to re-rate quickly and rotate from speculative to institutional ownership.